Hygea Medical Secures $28M in Series B Funding

According to PEdaily.cn, Hygea Medical Technology Co., Ltd ("Hygea Medical") has completed Series B funding of nearly 200 million yuan (US$28 million), led by Jianxing Medical Fund under the management of CCB International, with participation from Kunying Capital and Shuncheng Capital.

Hygea Medical is one of the state-level high-tech enterprises, providing the research and development, production and sales of medical products and focusing on the development of innovative medical products for cancers with minimally invasive and low-temperature technology. Hygea Medical uses leading biomedical engineering technology and advanced intelligent instrument and equipment manufacturing and has successfully developed the minimally invasive cryotherapy system for complex tumors.

Based on its experience in the fields of low temperature and minimally invasive technology targeting cancers, Hygea Medical is committed to developing innovative medical technology in the direction of national strategy. The company is going to make a series of advanced solutions in the field of minimally invasive cancer diagnosis and treatment. The company takes "we only care about your health" as the belief and “climbing the peak of technology in the world, improving China's medical industry" as the mission, striving to become cancer diagnosis and treatment industry leader in China or even the world.

Jianxing Medical Fund is an equity investment fund managed by CCB International and co-operated by Beijing New Aerotropolis Fund Management Co., Ltd ("New Aerotropolis Fund"). The fund focuses on high-quality projects in the growth stage of innovative drugs, high-end medical equipment, and intelligent medical treatment. CCB Medical Fund is a series of equity investment funds set up by CCB International to develop in the medical and health industry in China, including CCB Medical Fund I, Jianxing Medical Fund and CCB Medical Growth Fund, etc.

Kunying Capital is a private equity investment company focusing on long-term investment in emerging industries such as innovative technology, healthcare, Internet 5G&SaaS applications, and retail consumption. The company is committed to helping its portfolios to become bigger and stronger.